ArticleCureus2025
Establishment of a Novel Method for Dose Distribution Verification in Stereotactic Radiosurgery (SRS) Using General Semiconductor Array Detectors.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Stereotactic radiosurgery (SRS) involves steep dose gradients and small irradiation fields, which makes ensuring irradiation accuracy extremely important. While general semiconductor array detectors are reusable and cost-effective, their wide detector spacing results in insufficient spatial resolution. The aim of this study is to establish a novel patient-specific quality assurance (PSQA) method for single-isocenter multiple-target SRS volumetric modulated arc therapy (SIMT-SRS-VMAT) that can evaluate dose distribution with the same accuracy as radiochromic film by virtually narrowing the detector spacing by combining measurement with a general semiconductor array detector and translational movement of the treatment couch. Single-field plans with a single target and SIMT-SRS-VMAT plans with two targets were created for 1 cm lesions. Measurements using MapCHECK2 (Sun Nuclear, Melbourne, FL, USA) were combined with couch movement to synthesize measurement data at virtual detector spacings of 5, 4, 3, 2, and 1 mm. Root mean square error (RMSE) was used to evaluate profile shape accuracy, and γ analysis was used to evaluate dose distribution agreement. At virtual detector spacings of 10 mm, 5 mm, 4 mm, 3 mm, 2 mm, 1 mm, and with radiochromic film, the RMSE values in SIMT-SRS-VMAT were 8.02% ± 0.34%, 2.16% ± 0.07%, 1.60% ± 0.08%, 1.48% ± 0.17%, 1.32% ± 0.10%, 1.38% ± 0.03%, and 1.25% ± 0.02%, respectively. The RMSE decreased as the detector spacing narrowed, resulting in profile shapes comparable to those obtained with radiochromic film. In γ analysis, setting the virtual detector spacing to 5 mm enabled analysis covering the entire dose range, and the γ pass rate was comparable to EBT4 (Ashland Inc., Wayne, NJ, USA) for all tolerances. This study established a novel method of verification of dose distribution with the same accuracy as film, combining measurement with a general semiconductor array detector and translational movement of the treatment couch. With this approach, specialized high-resolution SRS array detectors and disposable radiochromic film are not needed, making SRS PSQA less costly and manpower-intensive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.